Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics (Q35033283)

5 August 2017

1 reference

title

Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics (English)

1 reference

5 August 2017

Phillip G Popovich

1

1 reference

PubMed ID

12498725

5 August 2017

T Bucky Jones

series ordinal

2

1 reference

5 August 2017

1 January 2003

1 reference

Trends in Pharmacological Sciences

5 August 2017

1 reference

5 August 2017

24

1 reference

5 August 2017

13-17

1 reference

5 August 2017

1

1 reference

The remedy may lie in ourselves: prospects for immune cell therapy in central nervous system protection and repair

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Restricted inflammatory reaction in the CNS: a key impediment to axonal regeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Innate immunity: the missing link in neuroprotection and neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Role of neutrophils in spinal cord injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: a potential new anti-inflammatory treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Spinal cord injury in the rat: treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Facial nerve transection causes expansion of myelin autoreactive T cells in regional lymph nodes and T cell homing to the facial nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Myelin antigen reactive T cells in cerebrovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

Nerve inflammation halts trial for Alzheimer's drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2900006-8

7 January 2021

10.1016/S0165-6147(02)00006-8

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12498725